Garcia Ruiz 2005.
Methods | A cost‐effectiveness analysis in the setting of the Spanish National Health System |
Participants | Patients with COPD |
Interventions | Tiotropium versus ipratropium or salmeterol |
Outcomes | FEV1, quality of life (SGRQ), dyspnoea (TDI), mean stay in hospital, exacerbations and direct healthcare costs associated with hospital treatment |
Notes |